Literature DB >> 21987280

Montelukast and maintenance of steroid-induced remission in eosinophilic esophagitis.

Levent Filik.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21987280     DOI: 10.1007/s10620-011-1923-4

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


× No keyword cloud information.
  12 in total

1.  Eosinophilic oesophagitis: treatment using Montelukast.

Authors:  R Sinharay
Journal:  Gut       Date:  2003-08       Impact factor: 23.059

2.  Observations on use of montelukast in pediatric eosinophilic esophagitis: insights for the future.

Authors:  J Stumphy; D Al-Zubeidi; L Guerin; F Mitros; R Rahhal
Journal:  Dis Esophagus       Date:  2010-11-12       Impact factor: 3.429

3.  Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis.

Authors:  Alex Straumann; Sebastien Conus; Lukas Degen; Stephanie Felder; Mirjam Kummer; Hansjürg Engel; Christian Bussmann; Christoph Beglinger; Alain Schoepfer; Hans-Uwe Simon
Journal:  Gastroenterology       Date:  2010-08-01       Impact factor: 22.682

4.  Anti-inflammatory properties of montelukast, a leukotriene receptor antagonist in patients with asthma and nasal polyposis.

Authors:  C Schäper; O Noga; B Koch; R Ewert; S B Felix; S Gläser; G Kunkel; B Gustavus
Journal:  J Investig Allergol Clin Immunol       Date:  2011       Impact factor: 4.333

5.  Eosinophilic esophagitis in adults, an emerging cause of dysphagia. Description of 9 cases.

Authors:  A J Lucendo Villarín; G Carrión Alonso; M Navarro Sánchez; S Martín Chavarri; S Gómez Senent; P Castillo Grau; J M Pascual Turrión; P González Sanz-Agero
Journal:  Rev Esp Enferm Dig       Date:  2005-04       Impact factor: 2.086

6.  Montelukast reduces peripheral blood eosinophilia but not tissue eosinophilia or symptoms in a patient with eosinophilic gastroenteritis and esophageal stricture.

Authors:  Brian E Daikh; Charlotte K Ryan; Robert H Schwartz
Journal:  Ann Allergy Asthma Immunol       Date:  2003-01       Impact factor: 6.347

7.  Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease.

Authors:  Evan S Dellon; Wood B Gibbs; Karen J Fritchie; Tara C Rubinas; Lindsay A Wilson; John T Woosley; Nicholas J Shaheen
Journal:  Clin Gastroenterol Hepatol       Date:  2009-09-03       Impact factor: 11.382

8.  Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder.

Authors:  Seema S Aceves; Robert O Newbury; Ranjan Dohil; Jeffrey Schwimmer; John F Bastian
Journal:  J Clin Gastroenterol       Date:  2007-03       Impact factor: 3.062

9.  Eosinophilic oesophagitis: a novel treatment using Montelukast.

Authors:  S E A Attwood; C J Lewis; C S Bronder; C D Morris; G R Armstrong; J Whittam
Journal:  Gut       Date:  2003-02       Impact factor: 23.059

10.  Eosinophilic gastroenteritis in a young girl--long term remission under Montelukast.

Authors:  Ivo Quack; Lorenz Sellin; Nikolaus J Buchner; Dirk Theegarten; Lars C Rump; Bernhard F Henning
Journal:  BMC Gastroenterol       Date:  2005-07-18       Impact factor: 3.067

View more
  1 in total

1.  Diagnostic and therapeutic strategies for eosinophilic esophagitis.

Authors:  Asifa K Zaidi; Ahad Mussarat; Anil Mishra
Journal:  Clin Pract (Lond)       Date:  2014
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.